The announcement directly pertains to NextCure and its financial health. It suggests that the company has sufficient funds to support its operations and capital expenditures for an extended period, which is typically viewed positively by investors as it indicates reduced financial risk and stability in operations. This can lead to increased investor confidence and potentially a positive impact on the stock price in the short term.